The qualitative latest Research report (2025-2032) on the U.S. 503B Compounding Pharmacies Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the ...

The beta-1 selective adrenergic antagonist esmolol is a desirable candidate due to its intravenous half-life of approximately 9 min, which closely mirrors that of DMT. Esmolol’s low lipophilicity ...

National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China Collaborative Innovation Center ...

Learn everything you need to know about Esmolol-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions ...

In the sensitivity analysis, ultra-short acting β -blocker use was associated with significantly lower mortality, with significant differences using esmolol vs landiolol. Use of the ultra-short-acting ...

Background: We report a case of a patient admitted to the cardiac care unit for evaluation of a non-ST-elevation myocardial infarction (NSTEMI) in the setting of atrial flutter (2:1) who developed a ...

Background Few trials have examined the efficacy of esmolol to attenuate hemodynamic and respiratory responses during extubation. However, the most appropriate dose of esmolol and an optimal protocol ...